Lisata Therapeutics (LSTA)

• Market cap: $24.4M
• 1 day: 4.49%
• 5 days: 20.26%
• 1 month: 6.49%
• 3 months: 12.5%
• 6 months: 17.72%
• Year to date: -21.85%
• 1 year: -1.41%
• 5 years: -87.76%
• 10 years: -98.6%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Employees: 26